NEW Prescriber Brief: Documenting Medical Rationale
APC's new Prescriber Brief was designed to help you coach the veterinarians you work with on what they must document on prescriptions for compounded animal drugs.
APC's new Prescriber Brief was designed to help you coach the veterinarians you work with on what they must document on prescriptions for compounded animal drugs.
We have a choice. To sit on the sidelines and let others determine our fate. Or get into the fight and tell our own story.
APC has an extensive library of on-demand webinars available—including EduCon 2023—for you to access whenever and wherever.
Over the past two years, The Townsend Letter has partnered with APC to alert prescribers and others about the threat to restrict compounded hormone therapy.
DEA's new proposed rule could affect compounded testosterone.
Here’s some good news: We’ve managed to buy you a few extra days to take advantage of our reduced hotel room rate for the conference. The new cutoff for special rates at Marriott’s Grand Hotel is NOW Tuesday, March 7.
Earlier this week, APC sent an updated briefing memo to all 50 state boards of pharmacy regarding GFI #256 and CVM’s recent responses to our questions regarding compliance.
We’re less than 5 weeks away. The cutoff date on our special (incredible) hotel rate of $189 at Marriott’s Grand Hotel is March 3.
Designation as an APC Fellow is the highest distinction awarded by APC, and the nomination process for 2023 is now open.
HHS has released its plan of work for the coming year, including a proposed release date for the latest iteration of the MOU on interstate shipments of compounded medications.
For those of you who weren’t able to register for this year's EduCon, there’s still time to sign up to access the 11 on-demand programs for CE credit. Click here to register and get started.
For those of you who weren’t able to register for EduCon last week, there’s still time to sign up to access the 11 on-demand programs for CE credit.
APC’s annual Owner Summit—March 26 to 28 at the Grand Hotel, Point Clear, Alabama—is THE conference that is 100 percent designed just for owners like you.
FDA’s Center for Veterinary Medicine responded this week to a July 26, 2022, letter from APC and NCPA requesting answers to more than 30 technical questions about GFI 256 compliance.
Congratulations to the 2023 recipients of the Pharmacy Compounding Foundation and Pharmacists Mutual Compounding Scholarship.
For compounding pharmacy and facility owners, APC’s Owner Summit is the top learning, planning and idea-sharing event of the year—and it’s only five weeks away.
Other voices have been telling the story of compounding—at FDA, in the halls of Congress, and in the media. To hear them tell it, you work in a dangerous, unregulated profession that puts patients at risk.
A big thank you and warm welcome to APC’s 2023 Corporate Patrons.
In a meeting last week with APC and NCPA reps, FDA Center for Veterinary Medicine’s Dr. Bill Flynn indicated that the agency’s stated April 1 date for commencing GFI 256 enforcement was not ironclad.
Check out the latest public policy update video from APC Director of Public Policy Savannah Cunningham, PharmD.
Late Thursday we learned that FDA has updated its January 20 GFI on ibuprofen compounding by 503Bs. The update would allow 503Bs to sell the ibuprofen suspension they prepare to 503A pharmacies.
Compounding the Joy is the third year of our 3-year media campaign to protect compounding. We initially focused on hormones (and that fight continues) but we are expanding our mandate to secure the future of all compounding.
EduCon is your key to being an effective team member in a well-run compounding operation. Don't miss it!
The Covid-19 national and public health emergencies are ending May 11, which means temporary guidance for industry that allowed 503As and 503Bs to prepare 13 COVID drugs for hospitals during the PHE will expire as well.
It's time to get a clue about the value of planning now— while you’re young (at heart?)—to assure you have the funds you need to live well into your, um, maturity.
In November 2022, APC submitted comments to Maine Board of Pharmacy on its proposed rule in Chapter 42 regarding compounding drugs for veterinary office use.
Join us on February 16 for a Virtual Town Hall. We will discuss the campaign, as well as the different ways that your involvement will help secure the future of our industry.
Last week we surveyed compounders about their knowledge of new laws, regs, and practice protocols. The results are in, and we’re seeing some holes in your expertise.
If you’re a pharmacy or facility owner who’s always looking for business-growing ideas and techniques to improve your operations, then APC’s 2023 Owner Summit, March 26-28, is for you.
Last Friday, FDA issued guidance on compounding certain ibuprofen oral suspension products...